RapidAI logo

RapidAI Funding & Investors

San Mateo, CA

RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients. RapidAI's platform uses artificial intelligence to create advanced images from non-contrast CT, CT Angiography, CT perfusion, and MRI diffusion and perfusion scans. It was founded in 2011 and headquartered in Menlo Park, California.

rapidai.com

Total Amount Raised: $100,000,000

RapidAI Funding Rounds

  • Series C

    $75,000,000

    Series C Investors

    Vista Equity Partners
  • Series B

    $25,000,000

    Series B Investors

    Lennertz & Co.
Funding info provided by Diffbot.